C World Wide Group Holding A Puma Biotechnology, Inc. Transaction History

C World Wide Group Holding A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$12.3 - $35.76 $481,901 - $1.4 Million	-39,179 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$20.07 - $46.7 $318,490 - $741,082	-15,869 Reduced 28.83%	39,179 $797,000
Q3 2018 Nov 05, 2018	SELL	$41.2 - $59.85 $392,924 - $570,789	-9,537 Reduced 14.77%	55,048 $2.52 Million
Q2 2018 Aug 03, 2018	BUY	$48.3 - $68.25 $1.97 Million - $2.78 Million	40,703 Added 170.43%	64,585 $3.82 Million
Q1 2018 May 03, 2018	BUY	$59.7 - $99.25 $120,952 - $201,080	2,026 Added 9.27%	23,882 $1.63 Million
Q4 2017 Feb 07, 2018	SELL	$93.85 - $132.45 $181,693 - $256,423	-1,936 Reduced 8.14%	21,856 $2.16 Million
Q3 2017 Nov 06, 2017	BUY	$72.0 - $119.75 $1.71 Million - $2.85 Million	23,792	23,792 $2.85 Million

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.